WHO ICTRP trial
Lapatinib In Chemotherapy-Naive Or Metastatic Breast Cancer
PER-027-04 · Registro Peruano de Ensayos Clínicos (REPEC) · Not Recruiting
Key facts
| Trial ID | PER-027-04 |
|---|---|
| Public title | Lapatinib In Chemotherapy-Naive Or Metastatic Breast Cancer |
| Scientific title | A MULTICENTER STUDY IN PHASE II, IN OPEN MODE, RANDOMIZED AND IN PARALLEL GROUPS COMPOSING TWO SCHEMES OF ADMINISTRATION OF GW572016 AS A FIRST LINE MONOTERAPY IN PATIENTS WITH ADVANCED OR METASTATIC BREAST CANCER |
| Primary sponsor | GLAXOSMITHKLINE PERU S.A., |
| Registry | Registro Peruano de Ensayos Clínicos (REPEC) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | II |
| Countries | India;Malasya;Pakistan;Singapore;Taiwan;Poland;Chile;Mexico;Peru;United States |
| Conditions | -C501 Central portion of breast Central portion of breast;C501;Central portion of breast |
| Interventions | Group name:1500 mg GW572016 Type of group;1 N° of participants:65 Intervention(s) description:GW572016 administered orally in doses of 1500 mg once a day Group name:1000 mg GW572016 Type of group;1 N° of participants:65 Intervention(s)… |
| Registration date | Nov 6, 2004 |
| Target size | 0 |
| Secondary IDs | NCT00089999 |
| Registry page | ins.gob.pe |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: